ArticleScientific reports2022
A hierarchical study for urban statistical indicators on the prevalence of COVID-19 in Chinese city clusters based on multiple linear regression (MLR) and polynomial best subset regression (PBSR) analysis.
Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Data-driven frameworks to robustly predict solubility parameter of diverse polymers.Scientific reports · 2025Article
- Environmental predictors of SARS-CoV-2 infection incidence in Catalonia (northwestern Mediterranean).Frontiers in public health · 2024Article
- Space and social distancing in managing and preventing COVID-19 community spread: An overview.Heliyon · 2023Article
- Discourse on COVID-19 Mass Testing vs. Rapid Testing Processing.Frontiers in public health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
With evidence-based measures, COVID-19 can be effectively controlled by advanced data analysis and prediction. However, while valuable insights are available, there is a shortage of robust and rigorous research on what factors shape COVID-19 transmissions at the city cluster level. Therefore, to bridge the research gap, we adopted a data-driven hierarchical modeling approach to identify the most influential factors in shaping COVID-19 transmissions across different Chinese cities and clusters. The data used in this study are from Chinese officials, and hierarchical modeling conclusions drawn from the analysis are systematic, multifaceted, and comprehensive. To further improve research rigor, the study utilizes SPSS, Python and RStudio to conduct multiple linear regression and polynomial best subset regression (PBSR) analysis for the hierarchical modeling. The regression model utilizes the magnitude of various relative factors in nine Chinese city clusters, including 45 cities at a different level of clusters, to examine these aspects from the city cluster scale, exploring the correlation between various factors of the cities. These initial 12 factors are comprised of 'Urban population ratio', 'Retail sales of consumer goods', 'Number of tourists', 'Tourism Income', 'Ratio of the elderly population (> 60 year old) in this city', 'population density', 'Mobility scale (move in/inbound) during the spring festival', 'Ratio of Population and Health facilities', 'Jobless rate (%)', 'The straight-line distance from original epicenter Wuhan to this city', 'urban per capita GDP', and 'the prevalence of the COVID-19'. The study's results provide rigorously-tested and evidence-based insights on most instrumental factors that shape COVID-19 transmissions across cities and regions in China. Overall, the study findings found that per capita GDP and population mobility rates were the most affected factors in the prevalence of COVID-19 in a city, which could inform health experts and government officials to design and develop evidence-based and effective public health policies that could curb the spread of the COVID-19 pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.